Skip to content

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course

Press Release

<< Back
07/06/2023

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course

 

Registration for limited seating open now

 

WILMINGTON, Del., July 6, 2023 – Ashland is collaborating with The Pii Center for Pharmaceutical Technology, University of Mississippi School of Pharmacy, to present The Advanced Hands-on Course in Tablet Technology at the Ashland state-of-the-art Research Center in Wilmington, Delaware.  

The course convenes Sunday, September 10, 2023, at 6:00 p.m. ET for registration and reception. Morning lectures from Monday through Thursday provide in-depth training in select areas of oral solid dosage form processing and manufacturing, followed by hands-on practice in afternoon laboratory sessions.

Lectures and labs will be conducted by external speakers from Merck & Co., Inc., Bristol Myers Squibb, Freund Vector Corporation, Medelpharm-Korsch AG, Leistritz Advanced Technologies Corporation, and GEA Group, in addition to lecturers from the University of Mississippi and Ashland.

“This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries who work in research and development, manufacturing, quality control assurance, or regulatory compliance,” said Thomas Durig, senior R&D director, life sciences, Ashland. ”The prerequisite is a fundamental understanding of the science of tablet technology and a desire to gain more knowledge and experience in advanced areas of design and practice.

To register and to see the full schedule, please click here.

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social, and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. Approximately 3,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com and ashland.com/ESG to learn more.

Trademark, Ashland, or its subsidiaries, registered in various countries.

  FOR FURTHER INFORMATION:

Media Relations:

Nancy H. Pitts

+1 (412)628-8791

nancy.pitts@ashland.com